PER 3.57% 8.7¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-422

  1. 13,207 Posts.
    lightbulb Created with Sketch. 1398
    https://knowablemagazine.org/article/health-disease/2021/could-immune-system-be-key-alzheimers-disease

    Based on the positive outcomes from the protein analysis reported above, Australian Provisional Patent Application No. 2021903024 was filed 20 September 2021 with claims covering applications of ATL1102 in new potential disease settings including diabetic, respiratory and age-related diseases to support the Company’s future commercial and partnering plans for ATL1102.

    Did anyone pick this up from the last Anp announcement..
    ”Age related diseases”
    The above link has been discussed on this thread previously….

    Alzheimers….$$$ huge market.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢
Change
0.003(3.57%)
Mkt cap ! $78.43M
Open High Low Value Volume
8.4¢ 8.7¢ 8.4¢ $72.99K 855.8K

Buyers (Bids)

No. Vol. Price($)
2 452608 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 398595 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.